- Zacks
Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Zacks
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
CRISPR Therapeutics AG (CRSP) reachead $59.60 at the closing of the latest trading day, reflecting a -1.6% change compared to its last close.
- Zacks
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $65.26, representing a +0.66% change from its previous close.
© 2024 Yahoo. All rights reserved.